Disease Burden of Invasive Meningococcal Disease in the Netherlands between 2011 and 2019
- Conditions
- Invasive Meningococcal Disease.
- Registration Number
- NL-OMON26020
- Lead Sponsor
- This study is funded by the Ministry of Health, Welfare and Sport (VWS).
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 330
Inclusion Criteria
Patients with IMD hospitalized in a Dutch hospital between 2011 and 2019 will be included.
Exclusion Criteria
Not hospitalized with IMD.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main objective of this study is to provide updated and representative information on the burden of IMD in the Netherlands between July 2011 and May 2020.
- Secondary Outcome Measures
Name Time Method we have established the following secondary objectives:<br>1.Describe the case characteristics of hospitalized patients with IMD in the Netherlands between July 2011 and May 2020.<br>2.Identify the clinical manifestation of IMD (e.g. meningitis and septic shock) in the Netherlands between July 2011 and May 2020.<br>3.Gain insight in the disease course (in specific the time between diagnosis and hospital admission) of hospitalized patients with IMD in the Netherlands between July 2011 and May 2020.<br>4.Identify the disease outcome(e.g. case-fatality and sequelae) of hospitalized patients with IMD in the Netherlands between July 2011 and October 2019